SCD and hepatocellular carcinoma: Thus, the accumulation of MUFAs by enhanced SCD activity promoted hepatocarcinogenesis, and reshifting the balance of FA composition toward saturation by SCD inhibition may be a potential therapeutic strategy for HCC.